Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Last Updated: 2026

Acurx Pharmaceuticals

Summary

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase IIa clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is based in Staten Island, New York.

History

Acurx was founded in 1982 with a mission to make medicines more accessible and affordable. Since then, we have expanded our product portfolio to include more than 90 prescription and over-the-counter products, making us one of the largest pharmaceutical companies in the world.

Mission

Our mission is to improve and save the lives of people around the world by developing and delivering innovative medicines, treatments and vaccines that enable people to live longer, healthier lives.

Vision

Our vision is to be the most trusted and preferred pharmaceutical company, providing high-quality medicines and services to people with the highest standards of safety, efficacy and affordability.

References

https://in.investing.com/equities/acurx-pharmaceuticals-llc

https://finance.yahoo.com/quote/ACXP/profile?p=ACXP

https://www.crunchbase.com/organization/acurx-pharmaceuticals

https://www.acurxpharma.com

Leadership team

Mr. Robert J. DeLuccia (Co-Founder & Exec. Chairman)

Mr. David P. Luci CPA, CPA, Esq., J.D. (Corp. Sec., Co-Founder, Pres, CEO & Director)

Mr. Robert G. Shawah CPA, CPA (Co-Founder & CFO)

Products / Services

Pharmaceutical

Number of Employees

0 - 50

Address

White Plains, New York, United States

Established

2017-01-01

Company Registration

SEC CIK number: 0001736243

Traded as

NASDAQ:ACXP

Website

https://www.acurxpharma.com

Last Updated: 2026

Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Learn More

Last Updated: 2026

Acurx Pharmaceuticals

Summary

History

Mission

Our mission is to improve and save the lives of people around the world by developing and delivering innovative medicines, treatments and vaccines that enable people to live longer, healthier lives.

Vision

Our vision is to be the most trusted and preferred pharmaceutical company, providing high-quality medicines and services to people with the highest standards of safety, efficacy and affordability.

References

https://in.investing.com/equities/acurx-pharmaceuticals-llc

https://finance.yahoo.com/quote/ACXP/profile?p=ACXP

https://www.crunchbase.com/organization/acurx-pharmaceuticals

https://www.acurxpharma.com

Leadership team

Mr. Robert J. DeLuccia (Co-Founder & Exec. Chairman)

Mr. David P. Luci CPA, CPA, Esq., J.D. (Corp. Sec., Co-Founder, Pres, CEO & Director)

Mr. Robert G. Shawah CPA, CPA (Co-Founder & CFO)

Products / Services

Pharmaceutical

Number of Employees